BRYAN CANNON to Anti-Arrhythmia Agents
This is a "connection" page, showing publications BRYAN CANNON has written about Anti-Arrhythmia Agents.
Connection Strength
0.486
-
Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome. Heart Rhythm. 2022 01; 19(1):81-87.
Score: 0.170
-
Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol. 2014 Aug; 7(4):664-70.
Score: 0.103
-
High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol. 2011 Oct; 32(7):896-903.
Score: 0.083
-
Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment. Pharmacotherapy. 2006 Dec; 26(12):1687-93.
Score: 0.061
-
Patterns of amiodarone-induced thyroid dysfunction in infants and children. Heart Rhythm. 2019 09; 16(9):1436-1442.
Score: 0.036
-
Outcomes of atrial arrhythmia radiofrequency catheter ablation in patients with Ebstein's anomaly. Europace. 2018 03 01; 20(3):535-540.
Score: 0.033